These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8791975)

  • 21. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
    Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; Gilbert R; Logan S; MacLennan S
    Cochrane Database Syst Rev; 2002; (3):CD002300. PubMed ID: 12137654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
    Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
    Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
    Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
    Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrence of reflux esophagitis can be prevented with maintenance therapy with sucralfate].
    Tytgat GN; Koelz HR; Vosmaer GD
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2432-7. PubMed ID: 8524425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of a 40-mg extended-release formulation of cisapride in the treatment of patients with gastro-oesophageal reflux.
    Katschinski M; Schirra J; Arnold R
    Aliment Pharmacol Ther; 2000 Jan; 14(1):113-22. PubMed ID: 10632654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sucralfate maintenance therapy in reflux esophagitis. Sucralfate Investigational Working Team.
    Tytgat GN; Koelz HR; Vosmaer GD
    Am J Gastroenterol; 1995 Aug; 90(8):1233-7. PubMed ID: 7639221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.
    Carling L; Cronstedt J; Engqvist A; Kagevi I; Nyström B; Svedberg LE; Thorhallsson E; Unge P; Wingren PE
    Scand J Gastroenterol; 1988 Nov; 23(9):1117-24. PubMed ID: 3073524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
    Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
    Farup PG; Hovde O; Breder O
    Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
    Cloud ML; Offen WW
    Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-daily sucralfate dosing to heal acute duodenal ulcer. Multicenter Study Group.
    Schubert T
    Am J Med; 1989 Jun; 86(6A):108-12. PubMed ID: 2660551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study.
    Elsborg L; Jørgensen F
    Scand J Gastroenterol; 1991 Feb; 26(2):146-50. PubMed ID: 2011701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.